0:00
How to how to a quick disclaimer before we get into the interview.
Search this video
0:01
The plants and compounds mentioned in this episode are legal in many countries and even possession can carry severe criminal penalties.
0:09
This episode does not constitute medical advice nor legal advice and should not be construed as a recommendation to use psychedelics.
0:18
There are serious legal, psychological, and physical risks.
0:19
Fatalities have been recorded.
0:23
So, psychedelics are not for everyone.
0:25
They can exacerbate certain emotional problems, certain diagnoses, and have been, as mentioned, in very rare cases, fatalities.
0:31
So, thanks for being safe, everybody.
0:51
Hello, boys and girls, ladies and germs. This is Tim Ferriss.
0:52
Welcome to another episode of The Tim Ferriss Show.
0:54
My guest today is a fan favorite, Dennis McKenna.
0:59
You can find him on Twitter @DennisMcKenna.
1:01
For Dennis has spent more than 40 years researching the interdisciplinary study of Amazonian ethnopharmacology and plant hallucinogens.
1:09
He has conducted extensive ethnobotanical fieldwork in the Peruvian, Colombian, and Brazilian Amazon.
1:15
His doctoral research at the University of British Columbia focused on the ethnopharmacology of ayahuasca and yagé, two tryptamine-based hallucinogens used by indigenous peoples in the Northwest Amazon.
1:25
He is a founding board member of the Heffter Research Institute, which has helped fund and directly funded a lot of very good science, and was a key organizer and participant in the ayahuasca project, the first biomedical investigation of ayahuasca used by the UDV, a Brazilian religious group.
1:41
He is the younger brother of Terence McKenna.
1:46
From 2000 to 2017, he taught courses on ethnopharmacology as well as plants in human affairs at the Center for Spirituality and Healing at the University of Minnesota.
1:54
In 2019, in collaboration with colleagues, he incorporated a non-profit, the McKenna Academy of Natural Philosophy.
2:02
Currently, the academy has several projects underway, with the most immediate being preparations for an upcoming conference in the UK, May 23rd to 26th, that's 2022.
2:10
ESPD 55, we're going to talk a lot about this, which will cover a wide range of topics related to psycho-ethno-pharmacology.
2:20
Dennis emigrated to Canada in the spring of 2019 with his wife Sheila and now resides in Abbotsford, British Columbia.
2:27
The website for the event that I just mentioned is espd55. com.
2:34
Dennis, welcome back to the show.
2:34
It's so nice to see you again. Thanks, Tim.
2:36
It's really great to be here.
2:38
Thank you for welcoming me back. Absolutely.
2:42
And I want to mention to folks right up front that the first episode covered a lot of ground.
2:46
I'm going to try not to duplicate too much.
2:51
The The title of the last episode, for people who want to check it out, is Dennis McKenna, The Depths of Ayahuasca, 500 plus sessions, fundamentals, advanced topics, science, churches, learnings, warnings, and beyond. So, you get the idea.
3:06
If you want to do a deep dive on not just Ayahuasca, but certainly a lot of your biographical details and more, listen to the first episode.
3:14
I'm going to try to deliver on the promise that I made at the end of the first episode, which was a teaser to a second conversation, which now we're in the very beginning of, during which I said we might get into, quote, the really strange and weird stuff, end quote.
3:29
So, I'm going to make an attempt to incorporate some strange and weird stuff.
3:35
I don't think it'll be very hard.
3:38
I thought we could start with a number of excerpts, highlights that I grabbed from The Brotherhood of the Screaming Abyss, which chronicles many of your life experiences, adventures, and misadventures alongside your brother and the many other people in your life.
3:55
And I'm just going to pull out a section here, and you can feel free to revise or update or now refute anything that I bring up.
4:02
But, here's here's the line.
4:07
They were an excellent complement to the cannabis.
4:08
We don't have to get into all the context before this, which we smoked constantly along with the occasional hit derived from the shavings taken from our fresh supply of Banisteriopsis caapi, the vine added to ayahuasca as a source of the MAO inhibiting compounds.
4:20
That's monoamine oxidase inhibiting compounds.
4:25
Here's the part I wanted to hear you expand on a bit.
4:26
We found that smoking the bark while on mushrooms synergized the closed-eye hallucinations in a most pleasant and intriguing way.
4:32
We dubbed this serendipitous discovery vegetable television.
4:37
So, could you speak a bit more, please, about the effect of adding the smoking of the bark to mushrooms and what that experience was or is like?
4:51
It was pretty much an accidental discovery, as so many of these things are.
4:55
But, we were You know, this is a good example of what happens, I guess, basically when you start mucking around with plants, you know, and doing stuff that maybe not be maybe not entirely safe, but you had to experiment.
5:10
It was just we stumbled on it.
5:12
We were taking a lot of mushrooms, and you know, that's a whole other story that we may or may not get into, but we were in a situation in the Amazon when we were doing mushrooms pretty much constantly.
5:26
And when you're doing them constantly, you get a certain tolerance built up.
5:31
And then you have to do larger doses to get any effect.
5:33
And we were, as as it says there, we were smoking cannabis pretty much constantly through this, too.
5:42
So, we decided to just Well, what would happen if we smoked some Banisteriopsis shavings on the mushrooms and it had this amazing effect, you know, which anybody can replicate and I don't think it's particularly dangerous, but we found that we could take a hit and then we would get this efflorescence of visions that would that would just gently rise and last, you know, two or three minutes and then just kind of fade away.
6:14
And then you could take another hit and you could repeat that.
6:16
It was kind of like going up and down in a balloon.
6:20
You could You could lose some ballast and go a little higher or you could come down.
6:25
It was very pleasant, actually. It was very nice.
6:31
If you look at the whole uh history of ethnopharmacology, for example, the ayahuasca, we think of ayahuasca as being essentially a mixture of two plants.
6:46
But that's very much a simplification of what ayahuasca is.
6:50
You know, there's a whole pharmacopoeia of of plants that sort of this galaxy of plants that that is associated with ayahuasca.
6:59
Not always taken with it, sometimes taken as admixture, sometimes taken as components of this dieta, which is very important in the in the sort of ayahuasca tradition, the training of the curanderos and so on.
7:16
And a lot of these plants are not very well investigated from a scientific point of view.
7:27
But the it it's it's an empirical science and and I I guess the I guess the point is you know, in some ways these practitioners, shamans, curanderos, they're really scientists in a certain sense.
7:42
They're experimental about it and they don't hesitate to say, "Well, what if I take this and mix it with that? What's going to happen?
7:50
How is that going to change the effect?"
7:52
Sometimes they really regret.
7:55
Those that survive this process, you know, make discoveries, but there is the potential to take the wrong things.
8:05
People may may think that ayahuasca has been pretty much figured out in terms of its botany, chemistry, pharmacology, and so on, but that's not the case.
8:15
There's a lot more to be learned about ayahuasca.
8:18
There's numerous PhDs left to be done and particularly these admixture plants are are interesting because some of them are uh you know, are psychedelic uh by themselves or regarded to be, but they may be used with ayahuasca.
8:34
So, this accumulated knowledge that exists in this sort of folk traditions, if you will, is not explored or not certainly not codified and it's ever-changing, right?
8:49
Like that's why there is no such thing as a standardized mixture of ayahuasca because there is different each preparation is as different as the practitioners that prepare it.
9:10
It has their sort of idiosyncratic stamp on it.
9:13
I want to underscore a few things that you said and then raise some additional questions.
9:22
So, first, I just want to reinforce how trial and error over hundreds or thousands of years can produce some very refined approaches to uh solving different problems and I think that this is well represented in areas that are perhaps a little bit more objectively accessible by most markers than say psychedelics.
9:46
If you look at poisons used in the Amazon, and I've certainly learned a lot about this from our mutual friend Mark Plotkin, who is an impressive fellow in his own right and has spent a lot of time in Suriname and other places. Mhm.
9:59
But if you look at curare for a very long time, for instance, Western scientists who later would take that and use it as the basis for a lot of modern anesthesia, saw that various species of pepper, wild pepper, were being added as admixtures to this poison.
10:18
And they, after failing to do any type of assay that that produced meaningful results, concluded that it was just primitive superstition.
10:29
And that was the conclusion for a long time until it was identified that I believe it's bioperine, and these constituent sort of molecules found in pepper can actually increase the bioavailability of these poisons such that they're faster acting.
10:41
And if you're shooting a monkey in the canopy, the last thing you want is for that tail to wrap around a branch when it dies so that it doesn't fall to the floor. Right.
10:52
And so lo and behold, it turned out that yes, there is there is a very practical purpose for the inclusion of this admixture.
11:01
And I'm sure there are some false leads, and there are things that kind of remain that won't be proven out in that same way.
11:08
But I do I think there's an argument to be made that as you said, a lot of PhDs are yet to be earned looking at these admixtures.
11:17
And just to provide a bit of context on the dieta, and please feel free to to jump in and add or refute anything that I say.
11:27
The dieta in many different tribes, in many different contexts, is the ingestion, in some in some cases the application, of plants that an individual is attempting to better understand or uh adopt and integrate as an ally.
11:46
And the ayahuasca is is viewed as a master plant or a teacher plant, uh you know, effectively in some capacity a vehicle for getting to understand and know these plants.
12:00
So, over a period of time, and sometimes it's done in a fasting context, other times it's a very bland diet.
12:09
These these plants may be not ingested at the same time as ayahuasca, but alternated, say one day on, one day off. Right. Um or or otherwise.
12:18
And then in certain cases, as you were mentioning, there are these psychedelics like uh like toé that are brewed with ayahuasca, uh which can be pretty dicey in in some cases.
12:32
I want to ask you about another paragraph, and that that will lead into my question.
12:38
So, so here's here's the paragraph.
12:40
In the next two or three sessions at Don Fidel's, I experienced the same sub-threshold effects.
12:46
It couldn't have been poor-quality brew.
12:49
Others in the group, including Don, were clearly affected.
12:50
It was something wrong with me.
12:53
For some reason, I wasn't getting it, in quotation marks.
12:56
Reflecting on those first experiences, I think that ayahuasca is in ways a learned experience.
13:01
If you don't know what to expect, nothing may happen.
13:03
Also, my uptight hyper-vigilance may have prevented me from relaxing enough to allow the experience to manifest.
13:11
Okay, so this paragraph highlights one one brand of sort of a null experience that I find most mystifying about psychedelics, because I I also had experiences, and and many others have where they will one out of 10, one out of 15, one out of every 20 sessions have absolutely no effect even from mega doses of ayahuasca and presumably your you know, serotonin type 2A receptors aren't just out to lunch for that period of time.
13:46
And so it it begets all sorts of questions.
13:49
So could could you speak to ayahuasca as a learned experience and also comment on if you have any thoughts these zero effect experiences.
14:06
Because in each case I can come up with a plausible explanation for why if it were possible for my psyche to negate an experience, it would have negated those experiences in those settings.
14:16
Uh but it's hard for me to make heads or tails out of.
14:20
It's very hard to do any kind of controlled study on this. Right. You can't do that.
14:25
I think what this speaks to is that ayahuasca or any psychoactive drug not just psychedelics, but it happens in psychedelics the experience is a combination of pharmacology pharmacogenetics, the way that your unique body, we're all you biochemically unique, and the way your body handles the absorption and the elimination of of the substance and the circumstances, set and setting.
15:01
This this dynamic of the environment that we harp on constantly as as the importance of set and setting.
15:11
I forget who it was, but some I think maybe it was Andy Weil who once made the observation, psychedelics are a kind of placebo in a certain way.
15:21
And if you take them under the wrong circumstances or inappropriate circumstances, you're not going to get any effect because it doesn't sync with the expectations that you may have or other things, and it just won't happen.
15:35
You have to surrender to it.
15:38
You literally have to surrender to it to let it happen.
15:42
But I think that this whole area of how the pharmacology and the expectations interact, it's a dynamic process that involves the medicine, your expectations, the dose, and your biochemical individuality and all that.
16:10
I mean, it's interesting.
16:10
For example, there are some people who Most of us, for example, smoke DMT and we're blown away, right?
16:21
I mean, DMT is hard to ignore if you smoke it.
16:23
It's profound, very quick, but very intense experience.
16:30
There are people who experience nothing, which is rather strange.
16:38
And and So, what's that about?
16:40
And without looking into well, okay, so what's unique about their serotonin pharmacology.
16:50
Maybe these people are like genetic knockouts, natural genetic knockouts.
16:55
Maybe they don't have high levels of 5-HT2A receptors, or maybe there's something maybe their MAO is super super active or super high.
17:11
But, you know, the problem, Tim, with with with studying this stuff is it it all comes down to these are case studies, right?
17:18
So, you can't do a controlled experiment, really.
17:23
You can't do a group and really study this effectively.
17:26
It's all about well, there's this one individual that no matter how much he takes, he or she takes DMT, is insensitive to it.
17:37
And we never did figure it out.
17:37
It never It never actually worked.
17:40
And I've heard other cases like that.
17:44
I've heard cases uh These are all anecdotal stories.
17:49
But, I heard a case of someone who, for example, was insensitive to DMT, but very sensitive to 5-MeO-DMT. Yeah. Why would this be? It's just a mystery.
18:06
What also just uh produces more questions than answers, certainly for me, is when you look longitudinally at the experience of a single person.
18:15
So, like their pharmacogenetics should be reasonably stable, you would think.
18:20
And let's just say, in my case, where I'm extremely sensitive to ayahuasca, generally speaking, and then in a handful of cases, have to, you know, two or three cups and absolutely zero discernible effect.
18:34
And I have my own subjective explanation for why that plausibly could have happened, but biochemically, I don't know how that is possible, right?
18:46
And now, because my expectation was that I would feel the effect.
18:51
And similarly, there are cases where, even if we remove the the the expectancy effect, there are certainly cases of people being dosed, let's just say, with LSD in any number of incarnations, and they end up tripping their faces off, even though they hadn't planned on spending the rest of their evening in the 17th dimension, right?
19:14
So So, I should also add just a quick note related to the the the smoking of the Banisteriopsis copy bark with mushrooms.
19:28
I've never experienced that.
19:29
I find that actually incredibly I'm not recommending it for all of the drug disclaimers and everything else, please revisit episode 1, but I will say everything we're discussing or a lot of what we're discussing can go terribly sideways.
19:45
Uh even if you are highly experienced, so we're not recommending you do any of these things.
19:49
Talk to your medical professional, etc. etc. Right.
19:50
However, all of that having been said, I find what you did more interesting than say what someone did who I may or may not know, which is ingesting harmine or harmaline or tetrahydroharmine orally in combination with ground psilocybin mushrooms, where you you hit the tennis ball or you hit the golf ball more accurately, and you can't unhit it. Mhm.
20:19
And in that case, just for people wondering, the multiplier effect on the subjective experience of mushrooms is about a a 3 to 4x.
20:27
So, if you were to take 1.
20:27
5 g of mushrooms and combine it with the MAO inhibitors in this way, the sort of subjective feeling is the intensity of 4. 5, let's just say. grams.
20:38
So, you want to be aware of that, but the smoking is super interesting because you can titrate that additive effect up or down. Exactly.
20:48
Which is the same reason why I found my experiences some of my experiences with intravenous ketamine very interesting versus intramuscular, for instance, because in real time you can dial up or down the intensity, assuming you haven't pushed yourself through the looking glass with a huge bolus in the very beginning.
21:09
In that case, forget about it. All bets are off.
21:12
But, if you're starting at a dose and a drip on a per like a It's kind of milligrams per kilogram basis over 60 minutes that you can manage a conversation with, then you can you can kind of dial it up and down, which is extremely extremely interesting because you're able to better observe the effects, at least.
21:37
Yeah, I mean, like you say, all the caveats, you know, about being careful with with anything like this, anything you're doing.
21:48
I I think that one should be careful.
21:51
One thing about the mushroom smoke that is stereopsis, you know, thing is that it does seem very gentle, very easy to control.
22:01
Again, your results may vary. Your mileage may vary. Everybody's different.
22:06
If you're super sensitive, I've always been a little puzzled why people would want to combine beta-carbolines with mushrooms because they don't require it. Yeah. They're orally active.
22:21
That's what sets psilocybin aside, you know, apart from DMT.
22:26
It does not require activation by a monoamine oxidase inhibitor.
22:32
And I'm a person that tends to think avoid combinations if possible because every drug you add into the mix complicates the pharmacokinetic picture and and everything else.
22:48
Potentially, makes it a little more hazardous.
22:50
So, I to the people that say, "Well, I can take a gram and a half of mushrooms and potentiate it with Peganum harmala and get a much higher effect.
23:02
My question is, well, why not take 4 g of mushrooms and let it go at that, you know?
23:09
Yeah, that is a much more straightforward approach.
23:11
Yeah, you'll get to the same place.
23:15
But this idea about titrating doses interesting.
23:18
That's another approach to DMT that you can take that's that's interesting, which I haven't worked with it that much, but vaping DMT in in a volcano vaporizer, I've had some of the most profound experiences with DMT that way uh because you can you you don't have to mess around with a pipe.
23:45
You just get the bag full of smoke and then you can deal with it.
23:47
If you put under your tongue sublingually a little bit of Banisteriopsis tincture like 10 minutes before you do this, then you can smoke the vapor in DMT and again, you get this ability to just gently rise up into the place and you can kind of maintain that for a while. Mhm.
24:11
And then you can sort of drift back down and then you can take another hit and you can go back up there, but you feel this sense of it it's very much less threatening.
24:21
I I you feel you don't feel this sense of being out of control.
24:26
When you just take three huge hits of DMT, it's it's kind of like, "Okay, we're jumping off cliff here.
24:34
Open the umbrella, hope for the best."
24:38
But this is a much more controllable way to approach it. Mhm.
24:41
And if it gets scary, well, you just let yourself down gently and come in for a gentle landing.
24:49
And if not, you can go to 28,000 ft or 50,000 ft or all the way into orbit if you want, if you So, I guess if there's a point to this route route and dosage and the way that you approach that is going to that's part of the dynamic, you know, of the set setting.
25:12
Drug, individual, setting, and dose.
25:12
And that includes route of administration.
25:20
I have, not surprisingly, a whole a whole slew of questions that I'd like to ask.
25:24
And I'm trying to I'm trying to sequence them so we can in some rational way because I think some could engender just a whole new branch of the conversation.
25:35
Let me Let me start with one that I've I've heard you discuss on some capacity before, but I can't remember the answer.
25:45
And I just love your help.
25:45
We're probably going to get into like phylogenetic trees and all sorts of stuff.
25:48
But, I heard someone talking not too long ago, and they said something along the lines of well, if you look at the fact that we have cannabinoid receptors in our brain, why else would we have those if it weren't for the fact that we were designed to consume cannabis.
26:08
You know, something along those lines.
26:10
I think the logic was was something like that.
26:14
How How would you explain the uh the prevalence or existence of receptors for these various types of of of molecules I know we could use Is it cannabinoids?
26:26
Is that how you say that correctly?
26:28
I'm not sure if I'm pronouncing it correctly.
26:30
What would your response to that be?
26:30
Or if you're sitting at a dinner table and someone brought that up, where would you take it?
26:36
I think it's not that complicated, actually.
26:38
The fact is, so we have cannabinoid receptors in our brains, and uh we have We actually have cannabinoids in our brains.
26:50
We have these these peptides called or these these prostaglandin-like compounds called anandamides and other types of things.
26:58
These are effectively their our brain's own cannabinoids.
27:03
Similarly, you see this with opiates.
27:08
Opiate receptors in our brain bind to these opiate peptides like endorphin and dynorphin and Right.
27:15
and those sorts of things.
27:18
And they just happen to bind to the alkaloids from opium. And have that effect.
27:24
Similarly with serotonin receptors or dopamine receptors, all of these have their own endogenous, the term is in endogenous ligands.
27:35
And obviously for serotonin receptors, there serotonin is the endogenous ligand.
27:42
But interesting new findings, Tim, show there's Formerly, there was a lot of there was excitement There still is excitement about endogenous DMT.
27:53
You know, and it's all related to the pineal gland and that sort of thing. Not so much.
27:59
The current understanding is that the pineal is not so important.
28:05
But DMT occurs in the brain in certain parts of the brain in rather high amounts in the frontal cortex.
28:11
And this hasn't really been discussed or studied as much as it should.
28:17
My friend John Chavez has gotten into this in rather deeply.
28:23
So, DMT is an endogenous ligand.
28:27
And DMT is a very simple molecule.
28:29
It's only two steps from tryptophan, which is in everything.
28:34
Which is one reason why you find DMT in plants, animals, fungi.
28:39
It you know, I sometimes in my lectures say nature is drenched in DMT.
28:44
It's not uncommon at all.
28:50
Oh, how did this come about?
28:50
Well, it came about because these neurotransmitter-like compounds found in the brain are also found in plants and fungi, and they have similar evolutionary origins, basically.
29:02
At some point the fungi, the animals, and the plants split off from each other.
29:10
There's this concept of the LUCA, you know, the last universal common ancestor, which was nobody knows what it was, but we know that it had to have existed.
29:24
And probably it probably it already had the the genetic machinery to make these neurotransmitter-like compounds.
29:32
And And just like neurotransmitters in the brain, what they do is they facilitate signaling.
29:40
They're signal transduction molecules, right?
29:45
But plants and fungi and everything else use very similar molecules, sometimes the same molecules, for signal transduction processes in the ecosystem.
30:00
Plants modulate their relationship with other organisms in the environment through signal transduction.
30:05
And these messenger molecules, the the plants make the the these sort of They're called secondary compounds.
30:15
And that implies that they're not important.
30:20
They're absolutely important.
30:20
But what they do plants substitute biosynthesis for behavior, right?
30:26
Plants modulate optimize their relationship with everything in the environment cuz they can't respond, they can't run away, right?
30:37
They're stuck in one place, so they do it through chemistry.
30:40
And sometimes, you know, this is like my usual rap, but sometimes the message is very simple. Stay away. Get away from me. I'm poisonous.
30:50
You don't want to muck with me, you know?
30:52
Other times, the message is, come closer. Let's symbios.
30:59
Let's form relationships.
31:01
All of this is mediated by these signal transduction processes, which is a which is a special kind of of signal signaling process in organisms that involves a receptor and a molecule that comes from somewhere outside or some other part of the brain and actually binds into that receptor.
31:25
So, it's a physical molecular interaction.
31:28
That's what I mean by signal transduction as opposed to, say, nervous electrical nervous transmission, which also takes place. Mhm. That's the miss.
31:41
It's not really a mystery.
31:43
It's uh we evolved from the same origins.
31:46
Not surprising that our brains have neurotransmitter-like compounds that resemble those we find in nature.
31:53
And the interesting thing is something like psilocybin is a good example.
31:57
Psilocybin has, you know, phylogenetically, we're pretty sure that psilocybin's been around for at least 75 million years.
32:08
The higher mushrooms, the basidiomycetes, are very old.
32:15
Long before there were animal nervous systems for them to interact with. Mhm.
32:20
But then, animals did evolve, and they turns out they have interesting effects with psilocybin.
32:29
What was psilocybin doing in nature before then? Well, probably insects.
32:32
It had to do with insects.
32:35
It was either an attractant or repellent.
32:40
More likely an attractant.
32:43
And there are some interest We could go down that rabbit hole, but there going to the going to the bar for the local insects. Right, yes. Effectively, yes.
32:51
I mean, you've heard of the psilocybin uh cicadas the story, right? I have not. Oh.
33:01
How did I miss the psilocybin cicada story? Sounds like a punk band. It does, really. Well, I don't know.
33:06
Do you want to go into it? I do. Yeah, of course I do. You kidding? Yeah.
33:13
So, very interesting study came out a few years ago.
33:20
So, cicadas are those things that spend like 17 years underground and then they come out every 17 years or different species come out at different times and so on.
33:33
Well, it turns out I mean, I I should be able to quote more detail, but if you Google this, it'll all come up.
33:40
So, cicada there's a fungus, which is not a psilocybe.
33:46
It's called Massospora is the fungus, but it makes psilocybin.
33:52
And it makes cathinone, which is a stimulant compound that's found in khat.
33:56
It's found It's the stimulant found in khat.
33:59
Well, Massospora infects these cicadas while they're in the ground, and it they take it over and when they emerge out of the ground, essentially their abdomen has been replaced by fungal sporangia, right?
34:19
This is kind of a grizzly tale.
34:21
They emerge out of the ground, and then instead of having a butt, basically, their tail is is replaced by these massive spore masses, and they're hypersexual.
34:32
They try to mate with anything that moves or even that doesn't move.
34:40
And they're waving around their butts and spreading spores everywhere, infecting more cicadas, and and this is how the fungus effectively the fungus has taken over the cicada and enslaved it into a turned them into sex-crazed zombies, if you want to put it that way.
34:58
And it facilitates Also a good punk rock band. A sex-crazed zombie? Yes, also a good one. Yeah.
35:05
And this is this is actually known in mycology.
35:08
There's another group of fungi called the cordyceps. Yeah, cordyceps. Same thing.
35:16
I mean, they don't use psilocybin, but they use uh they infect something like an an ant or caterpillar many many kinds of insects many kinds of species of cordyceps.
35:28
And they effectively will take over the insect's brain and direct its behavior.
35:38
For example, in ants, there are certain kinds of ants, they the fungus will infect the ant, doesn't kill it, but it causes it to climb up a blade of grass to the optimal position for spore dispersal, then it kills it.
35:56
Then it will explode out of its head with sporangia, and the spores will spread, fall to the ground, infect more ants. So, effectively Yeah.
36:08
these uh these cordyceps are are taking over the behavior of the ants.
36:14
Maybe psilocybin is doing something like that to us, except they don't have to infect our brain.
36:18
We happen to like it, so we consume it.
36:21
But we are we are serving the psilocybes' evil agenda, which isn't so evil.
36:27
It basically wants to reproduce and spread.
36:32
Nature has some crazy side effects out there.
36:34
I mean, I I pulled a crazy [ __ ] I pulled up I I pulled up I just searched cicada psilocybin and the first thing that pops up is an article and the headline is "These fungi drug cicadas with psilocybin or amphetamine to make them mate non-stop.
36:49
The insects keep at it even if chunks of their abdomens fall off."
36:55
And the uh the fungus is apparently Massospora cicadina, I think it is.
36:57
I'm probably mispronouncing that.
36:59
But, there are also cases, you know, mammalian cases.
37:03
I I can't recall the exact disease.
37:05
Uh I should actually be able to recall this, but it causes uh rodents to become suicidal in the sense that they become aggressive towards cats and effectively bait them. Yes. Yes.
37:20
the cats eat the rats or the mice and they contract this disease, which then has effects on cats.
37:26
I mean, it just goes on and on and on.
37:28
So, nature's got a lot going on, uh suffice to say.
37:32
a lot going on and and from a standpoint of like human ethics, this seems bizarre and crazy and and, you know, I mean, actually evil, but it's not.
37:43
It's just This is nature, nature in action.
37:46
And things try to optimize their survival strategies.
37:49
And for fungi, spreading and sporulating and all that, that's all they really want to do.
37:59
That's what they want to do.
37:59
If you want to attribute a desire to them, they're optimized for reproduction and they'll do anything.
38:08
They don't care if they have to take over primates and control Look at Look at how psilocybin's symbiosis, psilocybes' symbiosis with humans has been beneficial for us, right? Mhm.
38:24
and for the mushrooms because everybody's growing them.
38:25
They're growing them all over the place. Yeah.
38:29
And that's true of many plants and fungi.
38:31
If you domesticate something generally, if humans domesticate a plant or a fungus, that's like going on easy street for the for the organism cuz we're here to take care of it.
38:45
has domesticated the humans.
38:45
Until we blow up the planet completely entirely, but until then they have a pretty good free ride about it.
38:56
So, let me ask you a question about a comment you made in the Brotherhood of the Screaming Abyss about LSD as a potential treatment for dyslexia.
39:06
Now, I don't have all of the context, but I pulled this out and this is a is is going to lead to a broader question about perhaps unusual or unexpected applications or indications for psychedelics, but this this section here reads, "It did lead me to speculate about the use of LSD as a potential treatment for dyslexia.
39:25
We have a limited understanding of neuroplasticity, to say nothing of how psychedelics might affect it.
39:30
That man's anecdote, so of course I have omitted an anecdote, hints at the curious link between psychedelics and language, as do the more prevalent accounts of synesthesia I've discussed earlier."
39:42
And then I'll actually read one more sentence.
39:44
"Psychedelics have some fundamental relationship to the way our brains create meaning and understanding out of sounds and images.
39:50
I'm convinced that further investigations into this phenomenon would yield new insights."
39:56
Could you Could you expand on that because I would agree certainly with the the assertion of this fundamental relationship.
40:04
Any thoughts on LSD specifically as perhaps a a tool for addressing dyslexia or or psychedelics for any other indications that people might not guess?
40:15
The connection to LSD and language and I think even more so with mushrooms because you're probably familiar with an essay I think by Henry Munn that was published in a book called uh I think it was by Peter Furst called Hallucinogens and Culture. This was around 1970.
40:38
There's a wonderful chapter in there called The Mushrooms of Language. It's by Henry Munn.
40:44
And it makes the point and again, like I talked about this in The Brotherhood of the Screaming Abyss, you It makes the point that in this the mushroom state the poetry, the language becomes much more fluid.
41:01
It just sort of flows out of you and that's why these people can chant for hours and and they're actually instantiating you know, they're the mushroom is speaking through them.
41:15
This gnosis, literally this the logos is the word.
41:19
The true the pure logos actually flows through them.
41:22
And then there's the phenomenon of synesthesia.
41:27
Which psychedelics, especially mushrooms, can reliably do.
41:29
And you know, I've the association with meaningful images with sound.
41:33
Some people are naturally, genetically synesthetic.
41:40
And it's very often It's very interesting how their synesthetic experiences often have to do with words and numbers and things like that.
41:51
And they'll say things like, well, the number 13 is chrome-shaped and spiky.
41:59
You know, shiny and spiky. What?
42:03
But for them, that's a reality.
42:03
And I think, you know, I've argued that mushrooms, well, I have, Terence have, lots of people have, that mushrooms were important in the origin of consciousness.
42:15
So, I think that it is this this connection to language that consciousness depends what we understand as true consciousness depends on this construction of this worldview essentially, and that's built on language.
42:35
This artificial reality that we construct for us for ourselves that's a combination of sensory input that is filtered and processed in a certain way and linked to associations, memories, all of that kind of thing.
42:53
So, we build this you know, what the neuroscientists now call the default mode network, which is kind of ordinary creative consciousness.
43:03
Long before I heard of the default mode network, I was calling it the reality hallucination.
43:07
Effectively, we live in a hallucination.
43:11
We live in an artificial world reality that our brains construct.
43:17
And it must reflect whatever is out there cuz we're not wandering around stepping in front of buses and things like that.
43:25
So, it does map to reality in some ways, but it's a it's actually an impoverished version of reality.
43:34
What the a lot of what the brain does is filter things out, you know, and Huxley had this insight.
43:39
He talked about the reducing valve.
43:44
That to make the world comprehensible, you have to selectively filter what gets in.
43:52
And uh you're you inhabit this filtered You could almost use the word curated version of reality.
44:03
Otherwise, it would just be a blooming buzzing confusion.
44:05
And you wouldn't you wouldn't be able to navigate.
44:10
And then you can take a psychedelic, you can disable those mechanisms.
44:12
You can you can disable this default mode mechanism, open the gates of the reducing valve, and that can be very beneficial in terms of helping you get outside of your reference frame.
44:28
Uh and that's very useful.
44:31
I think that that's what psychedelics I think that's where the therapeutic effect really for many of the things it's indicated for, it's this ability to step outside your reference frame temporarily and look at your situation from a different perspective.
44:47
And uh but you wouldn't want to be there all the time, right?
44:52
Because you wouldn't be functional.
44:53
That's again why you have to be very selective about your set and setting when you do these things.
44:59
It's a complex topic because I think it does relate to the way that we link images, essentially internal images to sounds and meaning, effectively meaning.
45:16
Because I'm here rapping to you, right?
45:20
And I'm making effectively small mouth noises which are inherently meaningless except that we happen to share a language.
45:29
And so when I make these small mouth noises chances are your brain is reflecting it in terms of images.
45:39
I say chair, you see a chair.
45:39
I say star, you see a star.
45:41
So I mean it's more complex than that, but I think that's the basis of cognition, really.
45:49
And if you look at culture, if you look at if you look at consciousness, it's all based on this this relationship between sound image, and and meaning, or what they sometimes called portentousness.
46:08
And ascribed meaning, right?
46:08
It's a learned association that is not automatic, right?
46:12
I think about this a lot with say infants and language, and I'm sure there's someone who can comment on this much more intelligently than I can, but when an infant, let's say before they develop full depth perception and so on, if they were to look at what's in front of me, they wouldn't see laptop, webcam, microphone, wood table, etc.
46:40
pile of papers as discrete objects until they have likely, at least not to that level of fidelity until they have labels for those things, right?
46:49
It might just be a flattened, sort of two-dimensional sheet of colors and shapes and shadows.
46:59
And I I think about that quite a bit also as uh you know, you mentioned in the last episode that you've done who knows how many sessions with ayahuasca, you know, 500 plus, and it does seem that people develop, or
47:15
some people develop an ability to discern and see in those spaces in the same way that an infant sort of develops the ability to to discern between these kind of discrete things that we have labels for as adults, if that makes any sense at all. I'm not sure if that resonates at
47:33
I'm not sure if that resonates at all.
47:36
But I do think about that a lot, and I wanted to come back to something you said, which was uh you know, adopting a new reference point, and how that can be applied to many different, say conditions or issues.
47:47
And in some ways, you know, a lot of the outcomes that we see, or even the case studies that we might see in the case of this person with dyslexia or Andy Weil with his allergies, right?
48:01
Sort of defy conventional mechanistic explanations for how that could happen, right?
48:05
As like as far as I know, LSD is not an antihistamine, right?
48:10
So So it raises all sorts of questions.
48:11
And I I wanted to read this this is going to be the last section that I wanted to read to you and and I I realized that the Brotherhood of the Screaming Abyss was written quite a while ago.
48:24
So if if this goes to a dead end, I'll take the blame for it.
48:28
But I I pulled this out, which was a segment on Apollo 14.
48:33
It says, "This is another example of reference point changes.
48:36
So Apollo 14 is mostly remembered for the two golf balls that Alan Shepard hit with a makeshift club he brought with him.
48:44
It was also the mission on which, and this is the part that I bolded, Astra Edgar Mitchell, I'm guessing that's how that's said, had his famous Savikalpa Samadhi experience or mystical glimpse beyond the self into the true nature of things.
48:56
Mitchell subsequently became interested in consciousness research, paranormal phenomena such as ESP, and went on to become a founder of the Institute of Noetic Sciences or IONS. What happened to Edgar?
49:08
I don't actually know this story.
49:12
Well, I I think he had a mystical experience, basically.
49:14
And this was in space, while he was in orbit? In space, yeah.
49:19
Or on the moon, whatever.
49:19
But I think you know, we know these things happen spontaneously.
49:25
I think basically he he got so far out of his reference frame.
49:31
And who wouldn't be out of their reference frame if they're on the moon or in space, right?
49:34
And so he had a spontaneous mystical experience, you know, we are all one with the cosmos and all that and now if he'd been on psychedelics at the same time, he might have really But I I think that's what happens.
49:53
And and so that that speaks to the the idea that that this ability to step literally outside your box, outside of this default mode network is probably at the center of the psychedelic experience, at least in terms of its therapeutic effect and its its its profundity, if you will.
50:17
The the mystical experience or however you want to describe that.
50:24
I mean I mean Roland Griffiths and his people, even though they're the pioneers in looking at psilocybin and mystical experiences, but they really toned it down because they don't want to alarm people, you know?
50:38
And they talk they don't talk about mystical experiences anymore.
50:42
They talk about personally meaningful experiences. Well, Right.
50:49
that's nice, but they're they're mystical experiences, damn it.
50:51
I mean, they are they are experiences of transcendence and it's important, I think, to to acknowledge that. Oh, I agree.
51:03
I mean, they did also develop, you know, the I'm I'm probably getting the terminology wrong, but the sort of mystical experience questionnaire, which had Right. Right.
51:13
the parameters and characteristics, which include ineffability and so on, right? Right.
51:17
And some people just get this naturally.
51:19
I mean, for example, Albert Hofmann.
51:23
I mean, Albert Hofmann had numerous what you might call quasi or actual mystical experiences in nature long before he took LSD. I did not know that.
51:37
He was a person who was able to do this and it was very meaningful for him. Yeah.
51:44
And so so for people who don't have any context, Albert Hofmann, the first to synthesize, I guess LSD 25, was at the That was the one that got him off.
51:53
Yes, he still That was the one that he was called to take before he went on his bike ride. That's right. That's right. Yeah.
52:03
Uh There's a wonderful book. I I should Okay. I should mention.
52:06
I like to plug books, I guess others have written.
52:11
You've probably read it called Bicycle Day by Brian Blomers. I've heard of it. I haven't read it. It's a graphic novel.
52:19
It's a graphic comic novel about his discovery of LSD.
52:26
I I wrote the forward and Oh, amazing. It's a great book.
52:29
People should get Bicycle Day. Yeah.
52:32
So, Bicycle Day, we'll we'll link to that in the in the show notes.
52:34
I also want to mention a book that is related to a word and a concept and an experience, a phenomenon or phenomenon, I guess, that It's really a set of phenomena. Synesthesia.
52:45
So, there are two resources I want to recommend.
52:47
The first is a book that I first bought in I want to say late high school called The Mind of a Mnemonist.
52:56
So, the mind of, as in mnemonic device, The Mind of a Mnemonist, A Little Book About a Vast Memory, and it's written by A. R. Luria.
53:06
Or maybe it's with a forward by uh Yeah, Jerome S. Bruner. Written by A. R.
53:10
Luria, but it's it's effectively a case study of a Rain Man-like figure who experiences regularly experiences synesthesia, so this intermingling of the senses.
53:23
So, as you mentioned, kind of I identifying numbers as shapes or smelling colors, Mhm.
53:29
having tastes associated with musical notes or sounds, things like this, which can be either and in some cases both, an an enormous blessing or the most difficult curse Yes.
53:46
If it is something that you can't turn off. That's one.
53:49
There's also a I want to say documentary or may have been a TV series called Brainman about a young Brit at least at the at the time was young who experiences or claims to experience synesthesia.
54:03
As I understand it also fairly controversial.
54:07
Daniel Tammet is the figure in this one.
54:12
But still makes for a fascinating a fascinating watch.
54:16
And I think it's Kim Peek, the actual basis for Rain Man, who's also featured in that book who believe it or not can read two pages at the same time, one with each eye.
54:26
So, try to try that at home and see how far you get. Right.
54:33
But those are two points on synesthesia.
54:36
What I'd love to ask you about now is ESPD 55.
54:38
So, we should probably also provide some context. Maybe you can do this.
54:44
What ESPD stands for and just a bit of the history for those who don't have it and didn't hear the first conversation.
54:50
And then I would love to hear you describe some of what is going to be discussed, the why to do it, etc. Sure. Sure.
55:03
Because as you know, I have a collection of these sort of historical anthologies already.
55:07
ESPD is stands for ethnopharmacologic search for psychoactive drugs.
55:16
And in 1967, the National Institute of Mental Health sponsored a conference in San Francisco by that name.
55:25
And it was a closed conference.
55:29
The only thing the taxpayers ever got out of it was this book that they published, the proceedings of the conference.
55:35
Well, somehow or other, that came onto my radar at the age of 18.
55:42
And the next year, the year after the conference was done, it was somehow I got it and it opened up the world for me of ethnopharmacology.
55:52
Well, the government staged this conference, published this book.
55:54
They were supposed to have follow-up advance every 10 years or so to keep abreast of what was going on in the field.
56:03
Well, that never happened.
56:03
The the war on drugs came along.
56:08
They got real embarrassed, basically.
56:11
They'd never done anything, even though you could order it from the US government printing office for many years.
56:17
Well, so I always wanted to stage a follow-up and 50 years went by.
56:26
Circumstances never allowed that to happen, but in 2017 everything came together.
56:31
I had funding, I had a place, I had people to help me organize it.
56:34
And you know, I want to give a shout-out to them because it wasn't me that did it. I had a lot of help.
56:43
Some of them And so we did this this conference in 2017.
56:47
We did ESPD 50, this commemorative 50th anniversary conference and we uh we published the original 67 volume together with the 2017 volume as a box set.
57:04
You put the videos on The videos are still up there. People can watch them.
57:10
And so now it's been 5 years.
57:13
So we decided to do a 5-year follow-up.
57:17
God knows if I'll be here in 10 years, so you know, we decided to do a 5-year follow-up and that's what ESPD 55 is.
57:26
The 5-year from the 2017 conference or the 55th year of the first conference.
57:32
And that's the origin, that's the whole idea of it.
57:35
The 2017 conference was pretty much focused on ethnopharmacology and sort of the unexplored dark corners or you know, fringes of ethnopharmacology.
57:48
In other words, the the idea is the search for psychoactive drugs. It's It's a quest.
57:53
We're doing that this year.
57:56
We have some really interesting topics.
57:58
We have, for example, one person that's presenting on psychedelics found in sponges and, you know, marine sponges and that sort of thing.
58:10
But we've also got a couple forums.
58:10
We have three forums that don't really fit into this pattern.
58:14
One of them is a forum on coca and the need to destigmatize coca.
58:20
So, we've got Coca is a wonderful medicine as coca, not as coke cocaine is horrible.
58:30
Cocaine is a horrible drug, but coca is beneficial and coca is just at the center of Andean traditions and medicine and all that and potentially could be as a nutraceutical, as an herbal medicine, it could be very beneficial.
58:50
And there are all sorts of aspects cuz it give the people who grow it, who formerly were basically just told by the cartels, "Okay, you work for us now.
59:01
If you don't produce it, we'll just kill you."
59:05
But give those families, mostly, economic benefits and bring coca back as a as a respected medicine.
59:11
So, we've got Wade Davis in participating in this. We've got Andy Weil.
59:17
They're both of them are long-time advocates of of coca as a medicine and a and a food, actually, which it also is.
59:28
It's very nutritionally beneficial.
59:31
Now, I want to take a second just to get into some of the logistics of ESPD 55.
59:35
As a sidebar, I'll just say the box set of books for ESPD 50, you can find online.
59:45
You can find them on Amazon.
59:45
They're beautifully done.
59:48
I have them on my bookshelf.
59:48
Absolutely a joy to read.
59:53
For ESPD 55, people can find that at ESPD55. com.
59:58
I'll put that in the show notes.
1:00:00
And people can either attend in person in the UK May 23rd to 26th, this is 2022, or they can attend online.
1:00:05
Are those the the the two primary options that are available for folks? Yes, that's right.
1:00:12
And less less and less in person because because it's rapidly filling up, basically, the in person.
1:00:22
But, we tend tend to live stream.
1:00:22
And when we did the ESPD 50, we had at times we had 75,000 people participating.
1:00:32
We hope to meet or exceed that benchmark this time.
1:00:34
And uh there will be another book.
1:00:38
There'll be another There'll be a book that comes out of it, only one this time, but it'll be also high quality and it will match the you know, the design and everything to the previous one, so it'll look good on your shelf.
1:00:55
And the person that just that provided the art, that amazing, lovely watercolors that were incorporated into the design, she is uh there's a link to her website.
1:01:06
She's selling prints, essentially, print prints uh uh print sets of about I think uh about a hundred of her illustrations that people can order if they wish and they're beautiful so So Dennis, one thing I'd like to do to to sell this event if it's okay with you.
1:01:31
And we can cut this out if it ends up being more than you'd like to reveal, but I just want to give some teasers for folks.
1:01:39
I'm not going to give away too much or I won't give a lot of the specifics, but let me just give some other samples of sessions.
1:01:44
Is that okay with you, Dennis? Sure. Okay.
1:01:48
So there's a session on kratom.
1:01:48
A lot of people have questions about kratom, Mitragyna speciosa if I'm pronouncing that correctly.
1:01:54
Mitragynine, fascinating, fascinating plant. Mhm.
1:01:55
I'm going to put this in little gingerbread trail.
1:01:59
So I'm not going to fill in all the gaps, but a roadmap for sustainable development of ayahuasca production in the Amazon lowlands. Great interest to me. Yes.
1:02:09
Psychedelic fauna, so to be distinguished from flora.
1:02:12
I'll just put that I'll leave that alone.
1:02:15
I won't go into that too much.
1:02:17
Here's another, a history of psychoactive plants and fungi in Chinese medicine.
1:02:22
Something you do not hear in at least much that I have at all in mainstream conversations. Mhm.
1:02:27
You mentioned marine sponges.
1:02:33
Yield enhancing lessons from psilocin, which is what psilocybin is quickly metabolized into in the human body.
1:02:37
I guess that's probably what maybe first pass metabolism through the liver.
1:02:45
We've got hunting medicines among the Matsigenka, the Harpy's Gift and the Jaguar's Curse. Great title.
1:02:52
Huachuma, the sort of phytochemical profiling Huachuma.
1:02:54
Some people might know that as San Pedro cactus.
1:02:59
Also very interesting to me personally from a from a conservation and sustainability perspective because it grows so much faster than say peyote.
1:03:08
Mhm, which is endangered. Very, very endangered.
1:03:11
Added an anthro, so I'm going to leave that alone, but if people have never heard that word, A, it's a lot of syllables, B, fascinating history.
1:03:23
I mean, there is contemporary use, but that's kind of beyond the scope of of what we're talking about right this second.
1:03:28
Establishing collections of sacred psychoactive medicinal plants at Wasiwaska, that's in Floripa.
1:03:35
You have some amazing speakers.
1:03:35
I can just say, not as as the leading expert in this field, but as someone who is certainly an avid consumer and spectator {slash} tourist, do read a lot.
1:03:45
You have an outstanding roster of speakers.
1:03:47
Here's one you don't see every day.
1:03:50
Chemically induced otherworldly experiences of Zoroastrians in Iran. I mean, yes, please.
1:03:54
Would love to be part of that. Incredible.
1:03:58
I mean, where else are you going to find that?
1:04:02
Answer is probably nowhere.
1:04:04
And it just goes on and on and on.
1:04:04
So, I'll leave it at that.
1:04:07
There I I didn't even I I I didn't even cover 50% of it.
1:04:11
So, there's there's a lot here.
1:04:15
And there's there are many documentaries.
1:04:16
You have people who are very well known.
1:04:18
We didn't get into his resume at all, but Wade Davis certainly who's known for his books. Yeah, Paul Stamets.
1:04:27
Yeah, I mean, the whole idea of the ESPD conferences is that they're out of the box in a certain way.
1:04:35
It's not just the same stuff.
1:04:37
I mean, I'm happy that there are all these virtual meetings about the therapeutic uses of psilocybin and in PTSD and and addiction.
1:04:51
I mean, that's important stuff.
1:04:53
But there's a lot of duplication in some of these things.
1:04:56
We want to We want to kind of stake out an area and look into the obscure corners, but still important and and kind of highlight the the work that remains to be done.
1:05:10
For example, the Wachuma project is very interesting.
1:05:17
And and I can claim a little bit of credit for it.
1:05:20
The person that's going to present there primarily uh is uh a student of Wade Davis's actually in at UBC.
1:05:30
She's in the PhD program.
1:05:30
And then her partner and colleague uh a Peruvian gentleman Yosef I forget his last name, sorry, but they've collaborated on this.
1:05:43
And when I was asked to be on Laurel uh Laurel's Laurel Sungden is her name asked to be on her committee, I asked them if they I asked her if she was interested in in the chemistry side of this, the ethnopharmacology side of it, not just the ethnography.
1:06:04
And she indicated that she was that this was interesting to her.
1:06:08
So, we we hooked up with a investigator at the Albany College of Pharmacy who's developed an innovative way to non-invasive way to sample plants and and create you know, do uh like phytochemical fingerprints essentially.
1:06:29
A quick way to look at the variation in the different varieties and species of this cactus and then using mass spectrometry and other fancy tools actually do a like a phytochemical fingerprint of these different varieties and so on.
1:06:47
So, it's going to be a very interesting presentation that combines ethnography, chemistry, and pharmacology. Mhm.
1:06:55
Yeah, there's others like that.
1:06:59
Michael is going to talk about his work with the with the cultural key sold species, Michael Cole, and uh uh and then as you mentioned the people from ICEERS, we've got two two people from ICEERS that are talking about the whole issues related to the unintended consequences of ayahuasca tourism, basically. Yeah.
1:07:24
Depletion of the species and all of that and how do we address that?
1:07:30
So, I think it's going to be a stimulating conference.
1:07:35
So, you know, it's going to be it's going to be long.
1:07:43
So, let let me ask you this this might seem like a strange turn, but I want to ask you about life and death for a second because you you made a you cracked a joke earlier.
1:07:54
I'm not sure if it was totally in jest or serious, but you said, "I don't know if I'll be around here in 10 years, so we're going to do the fifth year new edition."
1:08:00
If you're open to talking about it, I mean, how do you relate to death and mortality?
1:08:04
How do you How do you think about that?
1:08:07
Relate to it in in any way you'd like to take a stab at that.
1:08:13
If there's anything to to be discussed.
1:08:15
Well, I relate to it in the sense that everybody has to die sooner or later.
1:08:26
Everybody crosses that threshold sooner or later.
1:08:30
And a lot of religious traditions and philosophical traditions and everything have to do with a focus on what happens after you die, you know, or when you die.
1:08:44
And but from a scientific perspective, I think the the only answer the only honest answer is nobody knows what happens when you die, when you really die.
1:08:56
There's lots of studies about the near death experience and then all the changes that happens during the near death experience.
1:09:05
The fact is that's not death.
1:09:08
You know, so that is maybe a reflection of the the stuff that happens to your brain while you're in the process of dying, but it is not in fact dying.
1:09:19
Is there anything that persists after death?
1:09:24
The honest answer I feel is I just don't know.
1:09:28
I'm open to the possibility.
1:09:31
I hope there is and but maybe not.
1:09:31
It's a case of be careful what you wish for, right?
1:09:37
I mean, like Shakespeare said, in that sleep of death, what dreams may come.
1:09:44
Hopefully they'll be pleasant if there is something or hopefully if there is something after death, hopefully there will be something worthwhile experiencing and not just terrible.
1:09:56
Or if there's nothing after death, if there's just oblivion, well, I won't be around to worry about it.
1:10:03
So So, either way, I'm okay with.
1:10:06
I don't plan to check out soon. I hope not.
1:10:08
I want to be around for ESPD 60 and 65 and 70, but let's face it, I'm I'm no spring chicken. I'm getting up there.
1:10:22
So, you know, I'm I'm 71.
1:10:22
I'll be 72 later this year.
1:10:26
So, not real old, but not real young, either. So, Yeah.
1:10:34
I think what I do is I think that I kind of take a leaf from the people, for example, that get psilocybin for end of life therapy, you know?
1:10:44
Very often the insight that they get from that is, well, yes, I'm dying, but I'm alive now.
1:10:54
And I'm sort of that's where I'm at.
1:10:56
I mean, we're all dying, Tim. Slowly, fast, whatever.
1:11:01
Important thing is we're alive now. Make the most of it. That's what I think.
1:11:08
So, you certainly seem to be making the most of it.
1:11:12
What are you most excited about right now?
1:11:15
While you are alive, which you are, like what is giving you the most joy and aliveness these days? Could be anything.
1:11:25
I think a lot of us are really concerned with things that are happening and the future looks pretty grim in a lot of ways. But you do what you can.
1:11:35
I I think that giving in to despair is not a solution for anything. And it's tempting.
1:11:43
I mean, you could just say things are so bad that there is no hope.
1:11:48
But then if you come to that point then there really isn't any hope.
1:11:54
So, you just keep plugging.
1:11:57
And to the degree that I can, I keep plugging.
1:11:59
And I've got many people who feel the same way.
1:12:06
Does any of it make any difference? I don't know.
1:12:09
But like the Bio noses project is a good example.
1:12:14
If we can slow down this this disappearance of knowledge and the and the disappearance of the habitats and the loss of species and all that just a little bit.
1:12:26
I mean, compared to what other groups and organizations are doing, probably Bio noses is a small thing. But it's it's our thing. It's what we're doing.
1:12:37
And I think maybe it'll make a little difference.
1:12:41
So, let me spell that for people.
1:12:41
So, Bio noses, just so we all have the spelling. It's b i o g n o s i s. Yes. A made up word. Right.
1:12:52
Biology bio life and gnosis knowledge. Knowledge. A a coined word really. Yeah.
1:12:58
But that that's the idea.
1:12:58
And people can find more about bionosis bridges to ancestral wisdom at bionosis. mckenna.
1:13:05
academy and we'll link to that in the the show notes as well.
1:13:10
Let me come back to a second for kind of slowing the degradation and depletion of our natural habitat.
1:13:23
This this sort of greenish blue marble that is spinning through space with a bunch of monkeys on it who are making a whole whole mess of things.
1:13:35
and and busy making a whole mess of it.
1:13:35
and busy making a whole mess of it. What is your current perspective on say synthetic options for psychedelic compounds in the sense that I found an an older interview where you were interviewed by Nailed Magazine and there was a bit of a discussion about you know synthetic/freeze-dried ayahuasca and you mentioned how and feel free to revise this but how you
1:14:05
felt that it's it may be a psychedelic but it's not ayahuasca because the ayahuasca experience begins when you taste it and the purging is potentially a feature and not a bug and I I I just be curious to know let's say in the case of ayahuasca what do you think some of the most viable solutions might be to avoiding over-harvesting and endangering these various plant species? Is the synthetic route, you
1:14:31
Is the synthetic route, you know, creating pharmahuasca alternatives viable, attractive, unappealing ill-fated?
1:14:42
What's what's your perspective?
1:14:46
I think we have to look at all all viable solutions.
1:14:48
For example, psilocybin psilocybin mushrooms don't really have that issue.
1:14:58
I mean, they're not endangered.
1:14:58
They can be grown by mega tons.
1:15:00
So, so we're not going to run out of psilocybin.
1:15:04
And maybe if we want to go with natural psychedelics, maybe we should emphasize those.
1:15:12
There is a lot of global interest in psilocybin.
1:15:17
And ayahuasca is endangered and and peyote certainly is endangered and things like iboga are endangered.
1:15:26
On the verge of extinction.
1:15:26
It's on the verge of extinction.
1:15:28
And I think part of the solution is number one, I think the community, the psychedelic community, to the degree that there is one, really has to step up and be responsible.
1:15:41
And I I think that the community should seek consensus.
1:15:44
For example, peyote is a good example.
1:15:47
The community like these D Crim movements that are happening across the country and in other countries and so on.
1:15:55
In general, I'm in favor of them.
1:15:57
But the indigenous people have asked, "Don't decriminalize peyote. Let it be our thing."
1:16:06
Well, I disagree with not decriminalizing it because uh fundamentally, I think no no plant, no organism should be criminalized.
1:16:16
I think the very idea is is repulsive to me.
1:16:18
But that said, the community can say, "Let's not criminalize it, but let's protect it.
1:16:29
And let's develop a community consensus that, 'Okay, we'll just put peyote behind a fence.
1:16:38
We'll say, "It's the indigenous people's thing.
1:16:40
We will not encourage on that.
1:16:42
We'll respect that and we'll avoid using peyote.
1:16:50
Some of these other things, Wachuma for example, Wachuma is a good source. It's not endangered yet. It's much more abundant. It's easier to grow.
1:17:01
That's a good alternative.
1:17:03
We're at a point with Wachuma where we can use it responsibly.
1:17:05
If we don't, then it too may become endangered eventually.
1:17:11
Ayahuasca is a very tricky one.
1:17:14
I think that Pharmahuasca's fine, but it's not ayahuasca.
1:17:17
It may have uses and that's it's a different drug.
1:17:21
It's it's completely different and I have nothing against synthetics, you know.
1:17:25
I think synthetics have their place and like I like to tell people, synthetics are they're made by all natural organic chemists, right?
1:17:37
So, they come from nature ultimately. Yeah.
1:17:41
But, what I would like to see happen, if if it could, is developing a you know, over time developing relationships with indigenous communities to produce medicines like ayahuasca, but not encourage people to go to South America to take ayahuasca.
1:18:02
Encourage these communities to produce them and and take the medicine to the people rather than people to the medicine.
1:18:13
Develop ways that are legal to export them to North America, Europe and so on and and through decrim establish centers where people can come and have these psychedelic experiences that are legal and safe and well-structured and all that.
1:18:32
And uh give benefits back to the people who produce it, who grow it economically.
1:18:42
Economic benefits, but kind of avoid the disruption of the culture that happens when all these rich gringos come down there to take ayahuasca. And I mean, I'm guilty.
1:18:54
I've organized lots of ayahuasca retreats.
1:18:59
I mean, I've seen tremendous benefits for people that come to those retreats, but I've kind of evolved in my view of it, whether that is a actually a good thing. Yeah. It is and it isn't.
1:19:08
And that's why decrim is important, but I think decrim has got to be very thoughtful and and clear in in its approach to this.
1:19:24
And say, well, you know, we're not going to encroach on things like iboga and ayahuasca. Or or do it in this way.
1:19:31
Bring bring the medicines north rather than the people south.
1:19:37
And that would transform communities as well, both in both places.
1:19:39
So, that's kind of This is not something's going to happen next week or next year.
1:19:44
This will take a decade or more, and it depends on how the laws can be can be changed. Yeah.
1:19:54
I I I would love to about this, you know. There's nothing simple.
1:19:58
There's nothing simple, and I I want to ask you a number of questions about the psychedelic community, as it were, with community in quotation marks, perhaps.
1:20:08
But uh before I get to that, I want to take uh maybe a uh not not exactly a counterpoint, but just to add my perspective on peyote for a moment, which is, you know, I believe that it's it's effectively inevitable that peyote is going to go extinct uh even with current demand by members of the Native American Church and uh very constrained production and distribution and also a lot of poaching. Yeah.
1:20:36
There there really only a handful of licensed, you know, peyoteros who can distribute and there are abuses of the system even within these these various kind of distribution channels.
1:20:50
I I really do feel strongly that this is one of the last shreds of let's just call it cultural though it's not true that peyote was widely distributed prior to Quanah Parker and Right.
1:21:04
other figures and initiatives, but it is it is so important to so many North American indigenous people that I I I and and also I'm guilty in the sense that like I have had experiences with peyote.
1:21:20
I've been invited by by the the people who are traveling through the proper channels and nonetheless spending time with a little bit of time, not a ton, but a little bit of time with the board of the indigenous peyote conservation initiative. Mhm.
1:21:36
It's a sad picture when you really look at it and you consider that, you know, these these indigenous groups generally are not going to want to consume peyote that is cultivated in greenhouses.
1:21:49
They're almost certainly not going to be open to synthetic mescaline or San Pedro. Right.
1:21:57
And just let them have it is my feeling and if if if a way to hedge against sort of bad or chaotic communal behavior is by leaving that one regulated in the way that it's regulated, I'm okay with that just because there are alternatives for people who are poor seeking some type of mescaline or mescaline you know, like analog experience.
1:22:25
But that's said, Tim, I mean, I agree with all that.
1:22:29
But what is really wrong with cultivated peyote? Yeah.
1:22:32
Why can't they see that as a viable part of the solution, not the whole solution?
1:22:39
It doesn't have to be wild. Yeah.
1:22:43
I mean, the the reasons that they're prejudiced against it or that they don't want to use it is they're they're spiritual reasons.
1:22:53
They're not scientific or cultural reasons. They could adapt.
1:22:57
They could adapt it Yeah.
1:23:00
to cultivated greenhouse, even tissue culture, these kinds of things. They could adapt to it.
1:23:06
But there has to be a little bit of give on both sides for this solution. I hear you. Yeah. I hear you.
1:23:15
I guess I I'll just And again, certainly I I wish we had some sort of indigenous representation here to hear their perspective.
1:23:26
It is, as you as as far as I understand, largely a spiritual matter, a sort of a a cosmovision Yeah.
1:23:34
facet of the belief system.
1:23:38
And if it's not coming out of the ground, there are there are ramifications and that peyote derived from the greenhouse is not the same, etc.
1:23:48
But I guess my perspective is there are so many battles to be fought.
1:23:50
This one's a pretty easy give. Mhm. them have it. Just let them have it.
1:23:57
Like, if you're if you live in Venice and you do like you're like into the ayahuasca scene and you have your green juice and you want to experience mescaline, don't do peyote. Just use something else. It's my Yeah. my my ask of the answer. have it. I'm all for it.
1:24:13
But even if you let them have it, it's still on the way out.
1:24:18
I mean, they'll still have the problem of the poachers and Yeah, they do. It's a mess. It's a mess.
1:24:24
it's really a mess and it's a shame because it doesn't have to happen.
1:24:29
I've spent time with a few I don't know if I they'd be considered botanists, but certainly scientists.
1:24:35
God, I wish I could remember one.
1:24:35
He was a fascinating character. Lives in Alpine, Texas.
1:24:38
He spent decades studying Lophophora williamsii, I guess it is and knows just the ins and outs of of cultivation also, but even if you were to have greenhouses, right?
1:24:52
How long does it take to cultivate even if you have the most advanced hydroponics or whatever you might use to accelerate the growth process? What are we talking?
1:24:59
10 years to grow a mature button? I mean Yeah.
1:25:01
And in some cases 15, 20.
1:25:03
I mean, so even with greenhouses you're facing incredible constraints on volume. So, there is that.
1:25:13
So, let's let's talk about this if you're open to it.
1:25:15
If you want to add something, please jump in. Well It's tough.
1:25:19
I mean, there's there's just no optimal solution for peyote and we're very impatient.
1:25:25
We're a very impatient species.
1:25:27
I mean, would the indigenous people have the insight or the patience to say, "Let's just leave Let's just stop for 10 years and work on developing the wild populations."
1:25:38
I mean, and who's going to administer that and who's going to make those decisions? Yeah.
1:25:46
It's just one of those things where it's hard to find consensus.
1:25:51
Everybody's got a different idea and we have a hard time listening to each other. So.
1:25:55
So, I wanted to I mean, this is maybe a a better conversation for like a a few glasses of wine or a few bottles of wine, but let me let me throw this out there.
1:26:05
So, the psychedelic community and I put it in quotation marks earlier.
1:26:12
It's like I maybe I'm just cantankerous and didn't get enough sleep night, but the psychedelic community or many components of it drive me absolutely [ __ ] bananas.
1:26:23
And I feel like I feel like it should be called the psychedelic infighting Olympics because if you if you want proof that psychedelics do not automatically create a Kumbaya world peace world of collaboration, like you need not look very far.
1:26:41
You just look at all of the infighting and kind of mutual crippling in this space and it is astonishing.
1:26:51
It is It is just astonishing to see and part of the reason this this comes up for me A because I'm kind of immersed in it as as as many people are as you are and it's so bad that I'm thinking about taking a little hiatus myself because it's it's so demoralizing for me to see.
1:27:14
The just absolute lack and this is not across the board.
1:27:17
There are many great people.
1:27:18
There are many people who are clear, ethical, effective, but then they're surrounded for every one of those I feel like they're just 10 idiots running around like chickens with their heads cut off swing machetes at everybody.
1:27:31
And this relates to a section in the Brotherhood of the Screaming Abyss.
1:27:40
So let me read something and and maybe we can I'll I'll let you grab the baton. So here it goes.
1:27:46
In many ways the Diggers tried to actualize the best ideals of hippiedom.
1:27:50
Like most utopian communities, however, they found it difficult to make reality fit with the ideal.
1:27:53
Inevitably they seem to founder on the recalcitrance of human nature.
1:27:57
For every idealist who is ready to pitch in and work for the common good, there is an opportunist who wants something for nothing or worse to grab power and bend it to his or her own ends.
1:28:06
And then dot dot dot dot dot.
1:28:09
You know, trying to run an egalitarian community in a dense city is a challenge under the best of circumstances and here's the part I I highlighted for myself and and every community that aspires to be spontaneous, to thrive without leaders or hierarchies must confront the vacuum it creates for the power crazed. Yeah.
1:28:26
I think that describes where we are today in so many different micro communities within the psychedelic larger {quotation mark} community {end quotation}. Yeah.
1:28:40
Uh maybe you can just talk me off the ledge.
1:28:42
I I think that we're monkeys, Tim.
1:28:45
Ultimately, we're monkeys and monkeys squabble and monkeys look for opportunities and you could look at any spiritual practice or any church, Eastern religion, ashrams, all of that.
1:29:00
I think anytime you're dealing with a spiritually powerful technology, which psychedelics are or other religious practices are, communion in the Catholic church, meditation and yoga in in Eastern traditions, these can also be used to control people, to to control people's
1:29:28
behavior and and in that context, there's always some power mad person, almost always a male, who sees an opportunity to sees the the levers of power to their own good and it's usually the motivations are I mean, so boring and so disappointing, but basically they're usually the same thing. It's usually about the chicks and
1:29:53
It's usually about the chicks and the money. I mean, I'm sorry.
1:29:58
That's what it's about, right? Yeah.
1:30:01
And people are motivated by those things and this idea that uh It's very Scarface. Yeah, effectively, yeah.
1:30:05
That psychedelics are going to dissolve the ego and turn us all into bodhisattvas and we'll all be kind and harmonious to each other.
1:30:16
It's just not going to happen.
1:30:18
I mean, it could, but we have to evolve into it, it seems like and and you have to be sincere about it.
1:30:25
There are always people who are looking for an opportunity to exercise power of one sort or another, financial, social, or otherwise, and psychedelics are not immune to this.
1:30:41
You and I know, I know lots of people who take lots of psychedelics.
1:30:47
They're still [ __ ] It's not a cure for that, you know?
1:30:49
It can help you again, step out of your reference frame and look at your situation.
1:30:58
You may have a revelation and say, "Oh god, I really am an [ __ ] I need to change my my whole behavior."
1:31:07
Many people are not interested in changing cuz so frankly, I don't know what to what to say, what the solutions are.
1:31:15
It all has to do with where the moral compass comes from.
1:31:18
You have to have some kind of an ethical framework that you work out of and it has to involve, you know, empathy, I think, is a big factor and just respect for other humans. Um it can be it's rare.
1:31:37
I mean, and I think psychedelics can be effective tools for learning this, but if you're a sociopath, it's probably not going to help you.
1:31:46
I mean, shaman I respected very much, I asked him who would he not give ayahuasca to.
1:31:55
And he said, "Well, there basically there are two kind two kinds of people that I would never give it to.
1:31:58
One is schizophrenics because it's not going to help them and the other is sociopaths because it's not going to help them either.
1:32:08
I would go so far as to say you could probably make both of those worse, right?
1:32:12
The schizophrenics certainly.
1:32:14
Like throw them again dash them up on the rocks of chaos and then the sociopath might just come back and say, I just need to do 10 times more than of what I'm currently doing.
1:32:24
Or they come back with some messianic delusion, you know, and that save the world I alone can fix it. Yeah.
1:32:34
It's something we have to evolve beyond.
1:32:37
I think that psychedelics are our co-evolutionary partners.
1:32:43
I think that they help us become better people but it's not you have to work at it, right?
1:32:51
Like any kind of spiritual, moral, ethical development.
1:32:57
It just doesn't you're not going to make it unless you actually try and believe in it.
1:33:05
And nobody succeeds 100%.
1:33:08
I mean, there are plenty of bad things about me, that's for sure, that I don't share with everybody, but I know what they are, you know, and and it's just tough.
1:33:17
It's just tough to be a a kind and gentle and and insightful and wise person.
1:33:24
That's kind of what we're here for though, I think. Yeah. Ah, yeah, what a world. Discouraging, right? Well, it's discouraging.
1:33:35
I mean, a part of me wonders because I'm uh still all things considered even though I've been uh you know, very involved for the last whatever 6 to 8 years kind of publicly new to the scene and I wonder, you know, of the of the more senior guard if you're looking at everything that's happening and you're optimistic, if you're like if you look at it and you say, "Well, yeah, a lot of shitty stuff is happening but like we've seen this before.
1:34:02
It'll shake out and hopefully we won't have the executive order to put everything back on schedule one and shut everything down which is not an impossibility, right?
1:34:10
And nor is it is it a solution. No. That's not a solution. Yeah.
1:34:17
I think we get caught up in the dynamics of the of the moment, too.
1:34:22
I think we have to step away, take the 30,000-ft level perspective and realize that these things are really co-evolutionary partners and we've been co-evolving with them well, pick your time, maybe for a couple men and years, you know, if we believe the stoned ape theory, which I do, basically. I I think it's credible.
1:34:46
I mean, we don't need to get into that.
1:34:48
But for a long, long time, we have co-evolved in effectively in sym- biosis with these plants and they've been sort of nudging us along on this very difficult path.
1:35:03
We're midway between the apes and the angels right now.
1:35:05
You know, we haven't reached haven't reached the angelhood yet.
1:35:10
We're still suspended but slowly but the thing is these these dynamics, these are really biological processes and they they play themselves out over millennia of time.
1:35:21
So, what's going to happen in the next 10 years, the next 50 years, that's a very small slice of time.
1:35:30
I feel that we're always going to have the relationship with these plants.
1:35:38
As long as number one, we don't drive them into extinction.
1:35:41
Number two, we don't drive ourselves into extinction. All these caveats.
1:35:45
But hopefully, they will be around for us to learn from and boy, do we have to learn?
1:35:52
We have a lot to learn still. Yeah. It's a slow process.
1:35:58
Let me ask you just a few more questions, Dennis, and then we can we can also cover anything you'd like to cover that I haven't brought up.
1:36:05
But let me ask you because I don't think I asked you last time.
1:36:09
If you could only have two, and this may not be the right adjective, so we can change the question, but if you could only have two psychoactive plants/substances for the rest of your life, what would you choose?
1:36:22
And I'm going to I'm going to make a few allowances here.
1:36:24
So, number one, you can have caffeine. Caffeine's a freebie. You get that.
1:36:28
So, you don't have to All right. Good.
1:36:33
So, you don't have to pick that.
1:36:35
And then for the sake of simplicity, we'll consider common cocktails, let's just say, like ayahuasca, we'll consider that a single plant. Yeah.
1:36:46
This can include synthetics.
1:36:46
It could certainly include things from the the natural kingdoms.
1:36:53
Which which two would you choose?
1:36:56
So, I only get to choose two? That's right.
1:36:58
We could start with three if that's easier, and then we we'll pair it down to two.
1:37:01
I like to enjoy asking people this question.
1:37:06
Now, I think mushrooms would definitely be one one of those.
1:37:11
And uh I think cannabis would be one. Mhm.
1:37:16
Which I don't use as much now as I used to, but I do I do use it.
1:37:22
I think of it as a beneficial very beneficial plant ally.
1:37:30
And uh Well, just in terms of my current state of health and all, I think those two uh ayahuasca would would I I'd like to also have access to ayahuasca.
1:37:42
What do you find the benefits of cannabis to be for you or what are the the ways in which you use it?
1:37:49
I think it just reduces stress. It helps me relax.
1:37:51
It helps me sleep and calm down and and it's good for insights.
1:37:59
I think it's good for writing for example.
1:38:05
Just a general balm to the spirit in a sense.
1:38:07
B A L M that kind of thing.
1:38:12
A nurturing my brother used to call cannabis sister Mary Redemptress. That's great.
1:38:20
Kind of like that, you know. It's kind of like that.
1:38:23
This benevolent loving feminine medicine.
1:38:29
And do you do you typically smoke?
1:38:33
Is that your preferred means of consumption? It has been, yeah. Yeah. I have tried vaping. I've tried edibles.
1:38:45
Neither one of those works for me.
1:38:48
But my cardiologist, I now have heart conditions that I have to worry about.
1:38:53
So my cardiologist said, "Don't smoke whatever you do, you know."
1:38:56
And I no matter how much no matter what you're smoking.
1:38:59
And I So I tried that for a while and finally I decided I tried vaping.
1:39:04
That was actually harder on my heart than it was smoking.
1:39:07
So what I do is I smoke tiny amounts in one of those cigarette-looking things and Yeah. seems to work.
1:39:17
I'm I mean it's sort of like I told my cardiologist.
1:39:19
I said, "Well, yeah, I can avoid all these things, but you know, I'm a I have to live, right?
1:39:23
I mean if if I die smoking cannabis, okay, so be it, you know." I'm at peace with that.
1:39:35
Do you have a any preferred uh I'm not even I'm no cannabis expert.
1:39:40
Are you preferred strain anything along those lines? No, not really.
1:39:43
I'm I'm from an era where long before any of that made sense.
1:39:47
If it's cannabis, if it's work if it works, I'm fine with it.
1:39:57
You know, I I I will say that I've only in the last few years really had proper exposure to cannabis, which take a while to unpack what the hell I mean by that, but I have a few novice takeaways are number one, I'm actually really glad I discovered it very relatively late in life because Yeah.
1:40:19
it could have been a real problem for me, I can tell.
1:40:23
And number two, the the two aspects, no, three aspects that have most impressed me are number one, the effects on sleep. Mhm.
1:40:33
Although it seems like you need to be careful so that you're not eliminating your REM cycles entirely, so it seems like you can certainly overdo it.
1:40:42
But just in terms of turning down the the volume and speed of mental chatter, Yes.
1:40:48
so that I can sleep, it's it's quite remarkable.
1:40:53
The second is how intensely it impr- seems to improve again.
1:41:01
I mean, who knows if someone were observing it, they might have a different perspective, but uh how intensely it affects and sensitizes my perception of music and production of music, say with percussion. Mhm. Unlike anything else.
1:41:19
Without I suppose of course the dose makes the poison, but at reasonable doses without the distortion that might accompany even moderate, say Sola 500s. Mhm.
1:41:28
And the third is how [ __ ] strong cannabis is now.
1:41:35
I mean, compared to like the few puffs I had in high school, I had two puffs with a friend recently and I laid down on my bed, thought I was going to have to skip dinner, and had full-blown visuals for a good hour.
1:41:45
I mean, it was I could not believe how psychedelic the experience was compared to many things that get lumped in under the umbrella of psychedelics like MDMA, which I don't consider a psychedelic, but my experience with really strong cannabis certainly I would say, I'd be curious to hear your perspective, would line up nicely with some of the descriptions of psychedelic experience.
1:42:16
Yeah, how do you think about that?
1:42:16
Yeah, I don't think of cannabis as a psychedelic, either, really.
1:42:22
For also for one thing, pharmacologically it certainly isn't, but I think with all these super strong strains that are available, uh you can get there more than before.
1:42:33
I mean, I've had it before before they had strong cannabis, there was hashish, which was always a a favorite, and you can get some pretty psychedelic places, especially if you eat hash.
1:42:47
And but now people are having cannabis ceremonies and they're effectively psychedelic ceremonies.
1:42:52
They're like ayahuasca sessions.
1:42:54
And I haven't been to any, actually, but but people do it.
1:43:01
And apparently And that's kind of interesting because here is a legal, pretty much legal medicine that people can use that way.
1:43:08
And I'm I'm in favor of it.
1:43:12
I think it's I think it's beneficial and there's no legal risk and and yeah, these strains are out there thanks to modern genetics, mostly.
1:43:25
So, I so just a couple things.
1:43:25
So, on the legal side, definitely check your local jurisdiction with listeners around the world.
1:43:32
So, check your local restrictions or laws around these things.
1:43:37
And I I will also just add because we're talking about a lot of compounds, a lot of different uses, that I haven't touched anything in at least 3 months, right?
1:43:48
So, it's not like I'm walking around with a fanny pack full of drugs all day hitting something every 2 to 3 hours.
1:43:55
I haven't touched anything except for a few glasses of wine in the last 3 months.
1:44:03
So, you should also, I would say as a not to be too like pedantic and yes, Dad, thanks for the advice, but I I think I think it is important and helpful to abstain for periods of time for at least the purpose of proving to yourself that you can do it. Yeah.
1:44:23
I mean, that's my perspective.
1:44:25
Dennis, is there anything else you'd like to mention like to comment on or add before we begin to to wind down this conversation?
1:44:33
Well, a couple of things.
1:44:35
I mean, we have pretty well covered the bases, Tim. This has been great.
1:44:40
You've You're very kind to spend so much time on this, but uh one thing I'd like to mention, you've quoted a number of times from the Brotherhood of the Screaming Abyss.
1:44:52
People may be interested to know that there'll be a second edition coming out toward the end of the year. Oh, no kidding. I know you did.
1:44:59
Yeah, they're going to reprint it.
1:45:01
I've written a new chapter.
1:45:03
So, it'll be the old one, but I've written a new forward and a new chapter for it.
1:45:10
And sort of in that sense try to bring it up to date because the book itself what it actually described ended in more or less with my brother's death in 2000.
1:45:22
And then the book itself was published in 2012.
1:45:24
Well, a lot has happened in the last 22 years.
1:45:30
So, uh so it's coming out.
1:45:30
Synergetic is going to reprint it, and it'll have this this amended chapter to it. So, that's one thing.
1:45:42
The other thing that we didn't really get into, and maybe it When we talked about bionosis, I don't know if people understand exactly what we're doing, but in a nutshell, what we're trying to do with this bionosis project, which is a long-term project and is actually going to cost considerable money if we if we do it right.
1:46:11
Basically, two aspects to it in terms of this knowledge recovery, knowledge preservation, and connection into science.
1:46:20
One is doing this series of documentaries on Amazonian traditional medicine.
1:46:30
The first documentary we we have a short They'll be short documentaries.
1:46:33
The first one will be showing at ESPD 55, and making a big pitch basically for support to make the you know, complete the series.
1:46:46
We conceive this as five to seven 30-to-40-minute documentaries that kind of is a snapshot of traditional medicine as it exists today in the 21st century in the Amazon.
1:47:00
And that's one aspect to it, but then linked to that is this much bigger long-term project has to do with the herbarium in Iquitos at the university in Iquitos, and and digitizing the herbarium.
1:47:18
It's got 100,000 specimens.
1:47:18
Only half those have actually been mounted.
1:47:25
But what we want to do is make high-resolution scans of those specimens, put them online in an accessible database that anyone can access.
1:47:32
And we actually have a an idea for creating a VR using VR and and AI technology to build what we're calling the visionary rainforest, which would be basically these collections distributed through this this virtual space, and just as a way of representing So, people if they can't go to the Amazon, they can immerse themselves in the visionary rainforest.
1:48:08
But it wouldn't be just a it would it would actually have information.
1:48:12
Each of the collections from the herbarium would be assigned to a place cuz they were collected someplace, right?
1:48:19
So, you go into this virtual environment and there'll be nodes that represent each collection.
1:48:26
You can click on a node, and that will open up the whole link to many forms of information.
1:48:31
Maybe information about traditional uses, about chemistry, about genomics, about all kinds of things.
1:48:39
So, make this a dynamic experienceable environment, but make it have scientific validity as well.
1:48:45
And so, this is a grand vision, and hopefully again, it will be a resource for anyone, for scientists especially, but really anyone that wants to uh you know, experience the I mean, the herbarium in Iquitos is kind of a run-down gradually eroding situation, but it's a gem.
1:49:17
It's an important resource.
1:49:19
All these plants are there.
1:49:21
What, 160,000 plus specimens?
1:49:25
Something like Yeah, about 100,000 specimens all together. Yeah.
1:49:28
And so we want to make that a real thing and turn it into a world-class resource for And the whole idea of this is I think it was uh Ralph Wal- Waldo Emerson is the one who said a a weed is a plant whose virtues haven't yet been discovered.
1:49:49
In that sense, every plant is valuable and to the extent that we can link information about these collections to to them, that gives them a value.
1:49:58
And I mean, they they don't need validation.
1:50:05
They don't need value from us to be valuable, but it gives them a value that we recognize.
1:50:11
So, we're going to talk about this this project.
1:50:13
And it's going to involve working very closely with the university there and they're all on board for it.
1:50:23
It's probably going to cost several million dollars to do this.
1:50:30
But I think we can get the money.
1:50:31
I think that people will see the value of it and and step up and do it.
1:50:36
And this is just in the overall scheme of things, it's just one little thing we can do to try to slow down what's happening in the Amazon because the Amazon is the Amazon is on fire along with the rest of the world and it's going to go away.
1:50:57
It will be lost forever if we don't do something about it in the next decade or so.
1:51:01
And by we, I mean humanity.
1:51:07
We're just our little academy and our little project is a small part of it, but maybe enough of a part of it to be a a catalyst in this.
1:51:18
I think that pretty much summarizes it that this Bionosis thing in terms of the nuts and bolts are these two components.
1:51:26
One is using videography to document and preserve this knowledge and make it compelling for people.
1:51:33
We want to do a Netflix series or National Geographic, whoever will take a look at it, and we want it to be something that people want to watch.
1:51:41
And then this other project is is obviously not separate from it, but but is a longer term and more ambitious thing of creating this virtual this visual rain forest that will live on the web and be accessible to people and benefit you know, the people in the Amazon and people worldwide that are interested in in these Amazonian plants.
1:52:12
So, that's that's the basic idea.
1:52:14
And people can find more on Bionosis and I will include this link along with links to everything else in the show notes for folks.
1:52:21
Bionosis b i o g n o s i s dot mckenna m c k e n n a dot academy and I'm sure if you just search Bionosis mckenna on Google that it'll pop right up. Yep.
1:52:34
And I encourage people also to check out espd55.
1:52:38
com another link that I'll include.
1:52:44
If the last two volumes are any indication and if the schedule is any indication, this should be a fantastic event and cover a lot of ground that I haven't even touched before.
1:52:59
And as a devout nerd in the space, I'm both ashamed and excited that that is true.
1:53:06
That's happening in the UK May 23rd to 26th, and you can also attend the live streaming online.
1:53:12
What I should mention, Tim, is one thing we will be we're talking to Synergetic next week, so you'll be able to pre-order the symposium volume for ESPD 55.
1:53:24
Just And you can still order the old one as well.
1:53:30
They still They still have that.
1:53:32
So, you can pre-order that there.
1:53:35
And the videos from ESPD 50 are still online and and they're open access, and I'll send you that link, and you can post that as well.
1:53:45
So, people can go back and watch those videos. Perfect. We'll include those.
1:53:53
I think we pretty well covered just about everything.
1:53:55
You've been incredibly generous with your time.
1:53:57
Life feels short sometimes, but it's also pretty long, and if I'm not going to spend time having conversations like this, what I'm in a rush to do a go fold my socks. I This is much more fun. Right.
1:54:10
People can find you on Twitter @DennisMcKenna the number four.
1:54:12
We will link to that in the show notes, as well.
1:54:18
The website for your academy is mckenna. academy.
1:54:23
And the links to everything will be in the show notes, tim. blog/podcast.
1:54:29
If you just search my name and Dennis McKenna, no doubt you'll find both of our episodes.
1:54:34
And that will be very, very easy to source. So, tim. blog/podcast.
1:54:39
Dennis, it is so nice to see you again. It's always fun. Always. This has been great fun.
1:54:45
We've just We just had an amazing rant here. This is lovely. Amazing rant.
1:54:51
We have a number of punk rock band names.
1:54:53
We have partial book title for your one of your next books, The Obscure Corners, which I like a lot. I took a note on that.
1:55:03
Which was drawn from something you said earlier.
1:55:05
And all in all just another extremely thought-provoking, very, very enjoyable conversation. So, thank you, Dennis. Thank you.
1:55:13
And to everybody listening, as always, thank you for tuning in.
1:55:19
And until next time, be just a little kinder than is necessary.
1:55:23
Take care of yourselves, be safe, and take care.